HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dan Su Selected Research

pamiparib

1/2021Human Mass Balance and Metabolite Profiling of [14 C]-Pamiparib, a Poly (ADP-Ribose) Polymerase Inhibitor, in Patients With Advanced Cancer.
1/2020Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dan Su Research Topics

Disease

119Neoplasms (Cancer)
05/2022 - 01/2004
27Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 05/2007
22Ovarian Neoplasms (Ovarian Cancer)
04/2021 - 09/2005
15Infections
01/2022 - 01/2009
14Breast Neoplasms (Breast Cancer)
12/2021 - 11/2006
14Neoplasm Metastasis (Metastasis)
01/2019 - 09/2005
12Carcinoma (Carcinomatosis)
09/2022 - 11/2006
11Adenocarcinoma
05/2022 - 02/2012
11Lung Neoplasms (Lung Cancer)
01/2021 - 09/2010
8Inflammation (Inflammations)
01/2022 - 09/2013
7Esophageal Squamous Cell Carcinoma
01/2021 - 01/2015
7Stomach Neoplasms (Stomach Cancer)
12/2020 - 02/2012
6Sleep Initiation and Maintenance Disorders (Insomnia)
11/2022 - 04/2013
6Hepatocellular Carcinoma (Hepatoma)
01/2022 - 10/2003
6Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 03/2012
6Adenocarcinoma of Lung
01/2021 - 06/2014
6Lymphatic Metastasis
01/2020 - 11/2011
6Disease Progression
06/2015 - 10/2007
5Pancreatic Neoplasms (Pancreatic Cancer)
02/2022 - 03/2014
5Carcinogenesis
12/2019 - 07/2009
5Ovarian Epithelial Carcinoma
04/2013 - 10/2007
4Atherosclerosis
01/2022 - 10/2015
4B-Cell Lymphoma (Lymphoma, B Cell)
12/2019 - 06/2014
3Critical Illness (Critically Ill)
01/2022 - 10/2019
3Anemia
08/2021 - 03/2014
3Obesity
03/2021 - 07/2010
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 02/2012
3Prostatic Neoplasms (Prostate Cancer)
01/2020 - 02/2015
3Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 10/2015
3Bacterial Infections (Bacterial Infection)
09/2019 - 12/2015
3Myocardial Infarction
11/2018 - 05/2015
3Sarcoma (Soft Tissue Sarcoma)
04/2016 - 01/2004
3Thrombocytopenia (Thrombopenia)
11/2015 - 12/2010
3Azoospermia
07/2010 - 05/2008
3Oligospermia (Oligozoospermia)
07/2010 - 05/2008
2Hemolysis
05/2022 - 01/2021
2Leukemia
01/2022 - 01/2016
2Hemorrhoids
01/2022 - 09/2012

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2005
15DNA (Deoxyribonucleic Acid)IBA
03/2021 - 01/2005
15Messenger RNA (mRNA)IBA
01/2021 - 10/2007
12Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2011
10Pharmaceutical PreparationsIBA
01/2022 - 03/2009
10Biological ProductsIBA
01/2020 - 01/2005
9EnzymesIBA
12/2020 - 01/2004
8MicroRNAs (MicroRNA)IBA
12/2021 - 07/2011
8RNA (Ribonucleic Acid)IBA
01/2021 - 01/2005
8ErbB Receptors (EGF Receptor)IBA
12/2017 - 09/2012
7CytokinesIBA
08/2021 - 05/2007
7PlatinumIBA
03/2021 - 11/2007
6Interleukin-6 (Interleukin 6)IBA
02/2022 - 05/2009
6Small Interfering RNA (siRNA)IBA
01/2020 - 01/2009
5Cisplatin (Platino)FDA LinkGeneric
03/2021 - 09/2010
5Therapeutic UsesIBA
01/2021 - 09/2012
5Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
12/2020 - 06/2012
4SaponinsIBA
05/2022 - 01/2019
4TriterpenesIBA
05/2022 - 01/2017
4Docetaxel (Taxotere)FDA Link
01/2022 - 07/2012
4GemcitabineFDA Link
01/2022 - 06/2012
4Indicators and Reagents (Reagents)IBA
11/2021 - 09/2017
4Glucose (Dextrose)FDA LinkGeneric
06/2021 - 06/2014
4Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021 - 01/2020
4Phosphotransferases (Kinase)IBA
01/2021 - 07/2008
4Antiviral Agents (Antivirals)IBA
01/2020 - 08/2006
4VaccinesIBA
01/2019 - 05/2009
4Anaplastic Lymphoma KinaseIBA
04/2016 - 07/2014
4StathminIBA
05/2013 - 06/2009
3LipidsIBA
01/2022 - 02/2014
3Peptides (Polypeptides)IBA
12/2021 - 10/2007
3AutoantibodiesIBA
08/2021 - 12/2010
3Estrogens (Estrogen)FDA Link
06/2021 - 03/2012
3CholesterolIBA
06/2021 - 03/2018
3LipopolysaccharidesIBA
03/2021 - 01/2012
3hydrogen sulfite (bisulfite)IBA
01/2021 - 06/2010
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2021 - 01/2020
3CateninsIBA
12/2020 - 10/2011
3CreatinineIBA
10/2019 - 02/2014
3Nucleic AcidsIBA
01/2019 - 07/2007
3Tyrosine Kinase InhibitorsIBA
12/2017 - 12/2013
3AlbuminsIBA
01/2017 - 07/2015
3AntigensIBA
01/2017 - 06/2010
3Estrogen ReceptorsIBA
01/2016 - 11/2006
3polyphyllin DIBA
01/2015 - 06/2014
3Caspase 3 (Caspase-3)IBA
01/2015 - 06/2014
3Gefitinib (Iressa)FDA Link
06/2014 - 12/2013
2Branched-Chain Amino AcidsIBA
05/2022 - 01/2020
2Competitive Endogenous RNAIBA
02/2022 - 01/2021
2AntibodiesIBA
02/2022 - 11/2006
2Analgesics (Analgesic Drugs)IBA
01/2022 - 02/2018
2Serum AlbuminIBA
01/2022 - 07/2015
22- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2022 - 03/2021
2Membrane Proteins (Integral Membrane Proteins)IBA
01/2022 - 01/2017

Therapy/Procedure

35Therapeutics
09/2022 - 08/2006
18Drug Therapy (Chemotherapy)
01/2022 - 05/2007
11Chinese Traditional Medicine (Traditional Chinese Medicine)
11/2022 - 07/2010
4Immunotherapy
10/2021 - 01/2017
2Adjuvant Chemotherapy
09/2022 - 04/2014
2Radiotherapy
06/2022 - 05/2007
2Operative Surgical Procedures
01/2022 - 01/2019
2Aftercare (After-Treatment)
12/2021 - 01/2019